• The Barrow Neuroplex
  • Find a Doctor
  • International Patients
  • Contact Us
  • Patients & Families
  • Education
  • Research
  • Departments & People
  • News & Stories
  • Transfer a Patient
  • Atogenpant for the Prevention of Chronic Migraine (PROGRESS)

    Enrollment Information

    Call (602) 406-8287 or Email [email protected]

    The purpose of this study is to look into the safety and tolerability of daily atogepant in the prevention of migraines. Atogepant is designed to block receptors in your head that may be related to migraine pain. Participants will have a total of 8 study visits over a period of approximately 20 weeks.

    About Barrow Neurological Institute
    Since our doors opened as a regional specialty center in 1962, we have grown into one of the premier destinations in the world for neurology and neurosurgery. Our experienced, highly skilled, and comprehensive team of neurological specialists can provide you with a complete spectrum of care–from diagnosis through outpatient neurorehabilitation–under one roof. Barrow Neurological Institute: Discover. Educate. Heal.